Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
SCHEDULE 13G Amendment No. 3 SIENNA BIOPHARMACEUTICALS INC COMMON STOCK Cusip #82622H108 Check the appropriate box to...
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File...
Sebacia Announces Leadership Update and Acquisition of Silver Photoparticle Technology Assets from Sienna...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:December 16,
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
As filed with the Securities and Exchange Commission on December 11, 2019 Registration No. 333-226595 &nbs...
As filed with the Securities and Exchange Commission on December 11, 2019 Registration No. 333-219609 Registration...
WESTLAKE VILLAGE, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA...
-- Sienna’s common stock to remain conditionally listed during the Chapter 11 asset sale process WESTLAKE...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관